Skip to content

Lidocaine Supplement for Minimal Invasive Parathyroid Surgery

Prevention of Laryngeal Reflexes in Minimal Invasive Parathyroid Surgery by the Use of Topical Lidocaine

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00528502
Enrollment
0
Registered
2007-09-12
Start date
2006-06-30
Completion date
2008-01-31
Last updated
2012-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parathyroid Disease

Keywords

Parathyroid Disease, Minimal Invasive Parathyroid Surgery, MIPS, Laryngeal Reflexes, Lidocaine, Saline

Brief summary

Primary Objective: 1\. To determine if the application of lidocaine to the airway will obtund or abolish the laryngeal reflexes. This in turn will lead to a quiescent controlled surgical field.

Detailed description

Lidocaine is a local anesthetic that causes numbness to the throat when misted into the air. This numbness in the throat should stop the urge to clear the throat in the middle of the operation. Therefore, this should stop the interruptions during the surgery. If you agree to take part in this study, you will be randomly assigned (as in the toss of a coin) to one of 2 groups. Participants in Group 1 will receive the saline mist. This will moisturize and soothe the throat. Participants in Group 2 will receive the lidocaine mist. Lidocaine or saline is misted into the air that you breathe during the surgery. You and your surgeon will not be told which group you were assigned to. At the end of the surgery, your surgeon will answer some questions to help determine if the use of lidocaine or saline is beneficial. You will be considered off-study once you are sent to the recovery room after surgery. This is an investigational study. Lidocaine is FDA-approved and commercially available for local anesthesia. If you are in the lidocaine or the saline group. Up to 105 patients will take part in this study. All will be enrolled at M. D. Anderson.

Interventions

DRUGLidocaine

Lidocaine is misted into the air that you breathe during the surgery.

DRUGSaline

Saline is misted into the air that you breathe during the surgery.

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All outpatients scheduled for MIPS at the ACB by Dr N Perrier, Dr D Evans and Dr JE Lee.

Exclusion criteria

* Patients who are excluded will be any who require elective endotracheal intubation as a preoperative decision by the anesthesia team. These patients will be those with sleep apnea, BMI\>35, uncontrolled gastro esophageal reflux. * Patients who have a history of allergy/hypersensitivity to lidocaine.

Design outcomes

Primary

MeasureTime frame
Severity of Airway InterruptionAssessment made by surgeon during minimally invasive parathyroidectomy surgery
Quality of Operative FieldAssessment made by surgeon during minimally invasive parathyroidectomy surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026